Myelin Foundry | $4,000,000 | (May 9, 2024)
Rad AI | $50,000,000 | (May 9, 2024)
Definely | $7,000,000 | (May 9, 2024)
Ablaze Pharmaceuticals
China
- Shanghai
- 29/11/2021
- Series A
- $75,000,000
Ablaze Pharma is a clinical stage Biopharmaceutical Company which is focused on the developing innovative Targeted Radiotherapy (TRT) to benefit cancer patients in China.
- Industry Pharmaceutical Manufacturing
- Website http://www.ablazepharma.com/
- LinkedIn https://www.linkedin.com/company/ablaze-pharmaceuticals-shanghai-co-ltd/
Related People
Tiecheng Alex QiaoFounder
United States -
San Diego, California,
Serial Entrepreneur experienced in high tech start ups. Twenty years of extensive knowledge in managing complex technologies and technology product development. A proven track record of conceiving and growing companies from concept to successful market entry, developing new product concepts, sourcing and managing co-development activities both in US and in China. Demonstrated success in building and leading multi-functional teams, strategic planning, and decision making. Also an inventor with 25 issued US patents and experience in developing and managing Intellectual Property.
Specialties: Conceiving and developing high tech business from concept to commercial success. Team building in high tech start up companies. Integrated product development and commercialization.
RunPod | $20,000,000 | (May 9, 2024)
Greenboard | $4,500,000 | (May 9, 2024)
Provable Markets | $8,000,000 | (May 9, 2024)
Lucid Bots | $9,100,000 | (May 9, 2024)
RLP, Rapid Liquid Print | $7,000,000 | (May 9, 2024)
In-House Health | $4,000,000 | (May 9, 2024)
Arbelos Markets | $28,000,000 | (May 9, 2024)
Ciba Health | $10,000,000 | (May 9, 2024)
Panax | $10,000,000 | (May 9, 2024)